Loxo Oncology Inc (fka LOXO)

[AugustStockInformer]

Genius stock analyst called this one weeks ago, see his other picks:
https://www.twst.com/news/citigroup-nysec-senior-analyst-explains-new-biotech-ecosystem-liquid-biopsy-cancer-genetics-nasdaqcgix-may-lead-personal-genomic-medicine-loxo-oncology-nasdaqloxo/

May 3, 2017
Yigal Nochomovitz, Ph.D. is a Director and Smid-Cap biotech analyst at Citigroup (NYSE:C) Investment Research & Analysis. In a recent interview with the Wall Street Transcript, Dr. Nochomovitz states that “Loxo has a drug for a rare type of cancer, and so it is going to need to engage with companies that are developing next-generation sequencing tests to do more genetic profiling of tumors.” Specifically, according to Loxo Oncology (NASDAQ:LOXO):